CVS MAXIMUM STRENGTH ANTI FUNGAL PEN 25

Manufacturer
CVS Pharmacy
Effective date
2024-12-12
Label type
HUMAN OTC DRUG LABEL
Version
7
Source
legacy-cache
Hydrated at
2026-08-01 20:46:19

Label at a glance#

ProductCVS MAXIMUM STRENGTH ANTI FUNGAL PEN 25
Active ingredientUNDECYLENIC ACID
Label structure7 sections

Indications and uses

For the cure of most For the relief of: ringworm (tinea capitis) athlete's foot (tinea pedis) itching scaling cracking burning redness soreness irritation and discomforts which may accompany these conditions

Dosage and administration

read all warnings and directions use only as directed clean the affected area with soap and water and dry thoroughly remove cap from pen twist the base of the pen, with brush pointing downward, until product dispenses apply a thin layer of the product over the affected area twice daily (morning and night) or as directed by a doctor for athlete's foot, pay special attention to spaces between the toes; wear well-fit...

Label contents#

Full prescribing information#

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Undecylenic Acid 25%

Purpose

OTC - PURPOSE SECTION

Anti-fungal

Uses

INDICATIONS & USAGE SECTION

For the cure of most

For the relief of:

  • ringworm (tinea capitis)
  • athlete's foot (tinea pedis)
  • itching
  • scaling
  • cracking
  • burning
  • redness
  • soreness
  • irritation and discomforts which may accompany these conditions

Warnings

WARNINGS SECTION

For external use only

Ask a doctor before use 

OTC - ASK DOCTOR SECTION

on children under 2 years of age

When using this product 

OTC - WHEN USING SECTION

avoid contact with the eyes

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • irritation occurs
  • there is no improvement within 4 weeks

Keep out of reach of children. 

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • read all warnings and directions
  • use only as directed
  • clean the affected area with soap and water and dry thoroughly
  • remove cap from pen
  • twist the base of the pen, with brush pointing downward, until product dispenses
  • apply a thin layer of the product over the affected area twice daily (morning and night) or as directed by a doctor
  • for athlete's foot, pay special attention to spaces between the toes; wear well-fitting, ventilated shoe, and change shoes and socks at least once daily
  • for athlete's foot and ringworm, use daily for 4 weeks. If condition persists longer, consult a doctor
  • supervise children in the use of this product
  • this product is not effective on the scalp or nails

Other information

OTHER SAFETY INFORMATION

  • Store at 15°-30°C (59° - 86°F)
  • Keep cap on pen when not in use

Inactive ingredient

INACTIVE INGREDIENT SECTION

Isopropyl Palmitate

Package Labeling:

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Outer PackageOuter PackageInner PackageInner Package

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 3 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
69842-83169842-831-03

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 2 matching rows.

Name, UNII, Kind table
NameUNIIKind
ISOPROPYL PALMITATE8CRQ2TH63MIACT
UNDECYLENIC ACIDK3D86KJ24NACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
29150e3f-8918-754e-e063-6294a90a67765ecc1bc6-8723-4d67-a2c7-99ca5737b40b2024-12-12WarningsExact identifier
spl id: 29150e3f-8918-754e-e063-6294a90a6776
spl set id: 5ecc1bc6-8723-4d67-a2c7-99ca5737b40b

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.